Hilary Johnstone
George, WC, South Africa
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Anti-Inflammatory Effects of Oral NLRP3 Inhibition With Ruvonoflast Among Individuals at Elevated Cardiovascular Risk.
Journal: Journal of the American College of Cardiology
Published: April 10, 2026
Anti-Neuroinflammatory and Anti-Inflammatory Effects of the NLRP3 Inhibitor NT-0796 in Subjects with Parkinson's Disease.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: April 08, 2025
A measles and rubella vaccine microneedle patch in The Gambia: a phase 1/2, double-blind, double-dummy, randomised, active-controlled, age de-escalation trial.
Journal: Lancet (London, England)
Published: December 17, 2023
Community-based management of a five-arm randomised clinical trial in COVID-19 outpatients in South Africa: challenges and opportunities.
Journal: Trials
Published: January 18, 2023
Efficacy, Safety, Tolerability, and Pharmacokinetics of MMV390048 in Acute Uncomplicated Malaria.
Journal: The American journal of tropical medicine and hygiene
Published: August 31, 2022
Comparing Prospective Incident Severe Acute Respiratory Syndrome Coronavirus 2 Infection Rates During Successive Waves of Delta and Omicron in Johannesburg, South Africa.
Journal: Open forum infectious diseases
Published: August 05, 2022
Randomized clinical trial of nitazoxanide or sofosbuvir/daclatasvir for the prevention of SARS-CoV-2 infection.
Journal: The Journal of antimicrobial chemotherapy
Published: March 07, 2022
Safety and immunogenicity of VPM1002 versus BCG in South African newborn babies: a randomised, phase 2 non-inferiority double-blind controlled trial.
Journal: The Lancet. Infectious diseases
Published: July 06, 2021
Safety, Tolerability, Pharmacokinetics, and Antimalarial Activity of the Novel Plasmodium Phosphatidylinositol 4-Kinase Inhibitor MMV390048 in Healthy Volunteers.
Journal: Antimicrobial agents and chemotherapy
Published: September 30, 2019
Safety and Immunogenicity of the Recombinant Mycobacterium bovis BCG Vaccine VPM1002 in HIV-Unexposed Newborn Infants in South Africa.
Journal: Clinical and vaccine immunology : CVI
Published: September 07, 2016
Showing 1-11 of 11
Last Updated: 09/26/2026